Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.

Translated title of the contribution: Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
Original language	Undefined/Unknown
Pages (from-to)	4938-4951
Number of pages	14
Journal	Human Molecular Genetics
Volume	22
Issue number	24
Publication status	Published - 2013

Access to Document

@article{863f3fc159ac4ebf9819a986843f258a,

title = "Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.",

author = "M.G. Morales and J. Gutierrez and C. Cabello-Verrugio and D. Cabrera and K.E. Lipson and R. Goldschmeding and E. Brandan",

year = "2013",

language = "Undefined/Unknown",

volume = "22",

pages = "4938--4951",

journal = "Human Molecular Genetics",

issn = "0964-6906",

publisher = "Oxford University Press",

number = "24",

}

TY - JOUR

T1 - Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.

AU - Morales, M.G.

AU - Gutierrez, J.

AU - Cabello-Verrugio, C.

AU - Cabrera, D.

AU - Lipson, K.E.

AU - Goldschmeding, R.

AU - Brandan, E.

PY - 2013

Y1 - 2013

M3 - Article

SN - 0964-6906

VL - 22

SP - 4938

EP - 4951

JO - Human Molecular Genetics

JF - Human Molecular Genetics

IS - 24

ER -